Perceptive Advisors LLC Avidity Biosciences, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $18.1 Million - $25.4 Million	-885,818 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$18.16 - $25.21 $3.51 Million - $4.87 Million	-193,210 Reduced 17.91%	885,818 $21.8 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $392,400 - $585,200	-20,000 Reduced 1.82%	1,079,028 $26.7 Million
Q1 2021 May 17, 2021	SELL	$20.28 - $28.15 $2.77 Million - $3.85 Million	-136,790 Reduced 11.07%	1,099,028 $24 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $32.9 Million - $38.9 Million	1,235,818 New	1,235,818 $31.6 Million

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.25B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.